A prospective global registry on oral antithrombotic treatment in patients with atrial fibrillation: GLORIA-AF Phase III baseline characteristics

被引：0
|
作者：
Huisman, M. V. [1 ]
Diener, H. -C. [2 ]
Dubner, S. J. [3 ]
Halperin, J. L. [4 ]
Rothman, K. J. [5 ]
Ma, C. -S. [6 ]
Lu, S. [7 ]
Paquette, M. [8 ]
Teutsch, C. [9 ]
Franca, L. R. [9 ]
Zint, K. [9 ]
Lip, G. Y. H. [10 ]
机构：
[1] Leiden Univ, Med Ctr, Leiden, Netherlands
[2] Univ Hosp Essen Ruhr, Essen, Germany
[3] Clin & Matern Suizo Argentina, Buenos Aires, DF, Argentina
[4] Mt Sinai Sch Med, New York, NY USA
[5] RTI Hlth Solut, Durham, NC USA
[6] Beijing Anzhen Hosp, Beijing, Peoples R China
[7] Boehringer Ingelheim Pharmaceut Inc, 90 E Ridge POB 368, Ridgefield, CT 06877 USA
[8] Boehringer Ingelheim Ltd, Burlington, ON, Canada
[9] Boehringer Ingelheim Int GmbH, Ingelheim, Germany
[10] Birmingham City Hosp, Birmingham, W Midlands, England
来源：
EUROPEAN HEART JOURNAL | 2018年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P3862
引用
收藏
页码：825 / 825
页数：1
相关论文
共 50 条
  • [21] Characteristics of Patients With Asymptomatic Atrial Fibrillation and Ischemic Stroke-Insights From the GLORIA-AF Registry (Phase 2)
    Heer, Tobias
    Zeymer, Uwe
    Schwarzbach, Christopher J.
    Seidl, Karlheinz
    Rauch-Kroehnert, Ursula
    Marler, Sabrina
    Teutsch, Christine
    Diener, Hans-Christoph
    Senges, Jochen
    Lip, Gregory Y. H.
    Huisman, Menno V.
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2025, 48 (01): : 42 - 49
  • [22] Renal function and adverse clinical events in anticoagulated patients with atrial fibrillation: insights from the GLORIA-AF Registry Phase III
    Liu, Yang
    Lam, Steven Ho Man
    Romiti, Giulio Francesco
    Huang, Bi
    Chen, Yang
    Chao, Tze Fan
    Olshansky, Brian
    Hong, Kui
    Huisman, Menno V.
    Lip, Gregory Y. H.
    GLORIA-AF Investigators
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2025, 58 (02) : 165 - 177
  • [23] Clinical Complexity Domains, Anticoagulation, and Outcomes in Patients with Atrial Fibrillation: A Report from the GLORIA-AF Registry Phase II and III
    Romiti, Giulio Francesco
    Proietti, Marco
    Bonini, Niccolo
    Ding, Wern Yew
    Boriani, Giuseppe
    Huisman, Menno, V
    Lip, Gregory Y. H.
    THROMBOSIS AND HAEMOSTASIS, 2022, 122 (12) : 2030 - 2041
  • [24] Incidence, characteristics, and prognostic impact of cancers in patients with atrial fibrillation: a report from the GLORIA-AF registry
    Huang, B., I
    Li, M.
    Liu, Y.
    Lam, H. M.
    Ishiguchi, H.
    Chao, T. F.
    Olshansky, B.
    Huisman, M.
    Lip, G.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [25] Diabetes mellitus and adverse clinical events in patients with atrial fibrillation: implications of insulin treatment: a report from the GLORIA-AF Registry Phase III
    Liu, Y.
    Chen, Y.
    Lam, S. H. M.
    Huang, B.
    Chao, T. F.
    Olshansky, B.
    Huisman, M.
    Lip, G. Y. H.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [26] Real world time trends in antithrombotic treatment for newly diagnosed atrial fibrillation in China: reports from the GLORIA-AF Phase III registry Trends in antithrombotic therapy use in China
    Liu, Xiaoxia
    Feng, Guoze
    Marler, Sabrina Vogel
    Huisman, Menno, V
    Lip, Gregory Y. H.
    Ma, Changsheng
    THROMBOSIS JOURNAL, 2023, 21 (01)
  • [27] When are atrial fibrillation patients at risk to discontinue anticoagulation treatment? Results from the GLORIA-AF Registry
    Paquette, M.
    Huisman, M. V.
    Lip, G. Y. H.
    Diener, H. -C.
    Dubner, S. J.
    Halperin, J. L.
    Rothman, K. J.
    Ma, C. S.
    Lu, S.
    Franca, L. Riou
    Teutsch, C.
    Zint, K.
    Nieuwlaat, R.
    EUROPEAN HEART JOURNAL, 2018, 39 : 1007 - 1007
  • [28] PREDICTORS OF ANTICOAGULANT PRESCRIPTION IN PATIENTS WITH ATRIAL FIBRILLATION IN NORTH AMERICA: THE GLORIA-AF REGISTRY
    McIntyre, William F.
    Conen, David
    Olshansky, Brian
    Halperin, Jonathan
    Hayek, Emil
    Huisman, Menno
    Lip, Gregory
    Lu, Shihai
    Healey, Jeff
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 413 - 413
  • [29] THE GLOBAL REGISTRY PROGRAM ON LONG-TERM ORAL ANTI-THROMBOTIC TREATMENT IN PATIENTS WITH ATRIAL FIBRILLATION (GLORIA-AF): FIRST ASSESSMENT OF BASELINE CHARACTERISTICS OF DABIGATRAN AND VKA COHORTS IN NORTH AMERICA
    Rothman, Ken
    Huisman, Menno V.
    Lip, Gregory
    Diener, Hans-Christoph
    Dubner, Sergio J.
    Ma, Chang-Sheng
    Teutsch, Christine
    Zint, Kristina
    Schoof, Nils
    Paquette, Miney
    Kleine, Eva
    Clemens, Andreas
    Bartels, Dorothee
    Healey, Jeff S.
    Halperin, Jonathan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A417 - A417
  • [30] Antithrombotic treatment pattern and baseline characteristics of dabigatran and vitamin K antagonist cohorts in North America - The GLORIA-AF registry program
    Huisman, M. V.
    Lip, G. Y. H.
    Diener, H. C.
    Dubner, S. J.
    Ma, C. S.
    Rothman, K. J.
    Zint, K.
    Kleine, E.
    Teutsch, C.
    Halperin, J. L.
    EUROPEAN HEART JOURNAL, 2014, 35 : 777 - 777
12345